China Resources Pharmaceutical Group Ltd.
3320
Rank in Stocks
#4275
China Resources Pharmaceutical Group Limited, an investment holding company,... China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the Teck Soon Hong brands. It distributes its products under the 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya, and Kun Zhong Yao to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
Share Price
$0.58910029
Last synced: 2026-10-16
Market Cap
$3.70B
Change (1 day)
-2.23%
Change (1 year)
-3.41%
Country
HK
Trade China Resources Pharmaceutical Group Ltd. (3320)
Category
Healthcare
EPS for China Resources Pharmaceutical Group Ltd. (3320)
EPS as of June 2026 TTM: $0.10
According to China Resources Pharmaceutical Group Ltd. latest financial reports and stock price the company's current EPS (TTM) is $0.10. At the end of 2023 the company had a EPS of $0.09 an increase over its 2022 EPS that were of $0.08.
EPS history for China Resources Pharmaceutical Group Ltd. from 2013 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.10 | 37.00% |
| 2024 | $0.07 | -17.22% |
| 2023 | $0.09 | 3.08% |
| 2022 | $0.08 | 9.74% |
| 2021 | $0.08 | 14.75% |
| 2020 | $0.07 | 0.45% |
| 2019 | $0.07 | -18.24% |
| 2018 | $0.08 | 16.05% |
| 2017 | $0.07 | -4.22% |
| 2016 | $0.07 | -8.13% |
| 2015 | $0.08 | 44.40% |
| 2014 | $0.06 | -0.18% |
| 2013 | $0.06 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.41 | 2,413.03% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $0.02 | -80.40% |
HK
|
